Acarbose/Orlistat

阿卡波糖/奥利司他

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAcarbose/Orlistat
Drug Alias Name阿卡波糖+奥利司他Acarbose+Orlistat奥利司他+阿卡波糖Orlistat/AcarboseOrlistat+Acarbose +[8] 
ClassificationSmall molecules
Mechanisms of ActionMaltase-glucoamylase inhibitorsGastric lipase inhibitors
TargetsMaltase-glucoamylaseGastric lipase
Therapy Area/IndicationsOverweightObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsYes AcarboseOrlistat
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEmpros Pharma
China Registration ClassN/A

Develop Information

Active CompaniesEmpros Pharma
Inactive CompaniesN/A
Active IndicationsOverweightObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A